Shannon Thyme Klinger, Chief Legal Officer at Moderna, Inc. (MRNA), sold 4,519 shares at $139.95 ($633K) on 2026-09-01, disclosed to the SEC on 2026-09-03.
Scheduled sale ($633k) by Chief Legal Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $139.95 | 3,471 | $486K | 76.8% |
| 2 | $140.34 | 1,048 | $147K | 23.2% |
| Total | $140.04 avg | 4,519 | $633K | 100% |
| Filing → |
| MRNA | SELL | 2024-12-10 | $24K | — | Filing → |
| MRNA | SELL | 2024-12-04 | $5K | — | Filing → |
| MRNA | SELL | 2024-12-02 | $121K | — | Filing → |